Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Equilis Te   
Auth. number : EU/2/05/055
Active substance : Not available
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI05 - Immunologicals for equidae
Pharmacological subgroup: QI05A - Horse
Chemical subgroup: QI05AB - Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia)
Chemical substance: QI05AB03 - clostridium
(See WHO ATCvet Index)
Indication: Active immunisation of horses from 6 months of age against tetanus to prevent mortality
Marketing Authorisation Holder: Intervet International B.V.
Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/07/2005 Centralised - Authorisation EMEA/V/C/93 (2005)2737 of 08/07/2005
21/05/2008 Centralised - Variation (no change in Commission Decision) EMEA/V/C/93/II/2
15/07/2008 Centralised - Variation EMEA/V/C/93/X/1 (2008)3714 of 11/07/2008
11/05/2010 Centralised - Variation (no change in Commission Decision) EMEA/V/C/93/IG/1
29/07/2010 Centralised - Renewal EMEA/V/C/93/R/3 (2010)5324 of 27/07/2010
12/06/2015 Centralised - Renewal EMEA/V/C/93/R/6 (2015)4104 of 10/06/2015
20/09/2016 Centralised - Variation EMEA/V/C/93/IA/7/G
Updated with Decision(2017)6280 of 14/09/2017
18/09/2017 Centralised - Yearly update (2017)6280 of 14/09/2017